Company Overview: Harrow, Inc. (NASDAQ: HROW) is a North American ophthalmic pharmaceutical company focused on developing, commercializing, and providing accessible branded and compounded therapies for a broad range of eye-care conditions, including dry eye disease, glaucoma, cataracts, retinal diseases, and ocular-surface disorders. Its portfolio has expanded through acquisitions, licensing and internal development, with key products including IHEEZO, VEVYE, TRIESENCE and BYOOVIZ, supported by its ophthalmology-focused commercial platform. Foraco International SA (TSX: FAR) is a global drilling-services provider serving the mining, water, energy and geotechnical sectors, with operations across five continents and a fleet of more than 260 drill rigs. Its core activities include mineral exploration and production drilling, water-well and mine-dewatering services, and specialized drilling solutions for technically complex and challenging environments.

This Report covers the Price Action, Technical Indicators Analysis along with the Target Levels, Stop Loss Level, and Recommendations on these two stocks.

Past performance is not a reliable indicator of future performance.